Previous Article | Next Article ![]()
Molecular and Cellular Biology, December 2001, p. 8276-8288, Vol. 21, No. 24
Department of Immunology, The Scripps
Research Institute, La Jolla, California 92037
Received 28 June 2001/Returned for modification 20 August
2001/Accepted 12 September 2001
We used retrovirus insertion-mediated random mutagenesis to
generate tumor necrosis factor (TNF)-resistant lines from L929 cells.
Using this approach, we discovered that the plasma membrane calcium
ATPase 4 (PMCA4) is required for TNF-induced cell death in L929 cells.
Under basal conditions, PMCA4-deficient (PMCAmut) cells
have a normal phenotype. However, stimulation with TNF induces an
abnormal increase in the intracellular calcium concentration ([Ca2+]i). The substantially elevated
[Ca2+]i caused resistance to TNF-induced cell
death. We found that an increase in the total volume of acidic
compartments (VAC), mainly constituted by lysosomes, is a common event
in cell death caused by a variety of agonists. The increased
[Ca2+]i in PMCAmut cells promoted
lysosome exocytosis, which, at least in part, accounted for the
inhibition of TNF-induced increase in VAC and cell death. Promoting
lysosome exocytosis by calcium inhibited TNF-induced cell death in
wild-type L929 cells, while inhibition of lysosome exocytosis or
increase of VAC by sucrose restored the sensitivity of
PMCAmut cells to TNF-induced cell death. Thus, increase of
the volume of acidic compartment is a part of the cell death process,
and the antideath effect of calcium is mediated, at least in part, by
inhibition of the TNF-induced increase in VAC.
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.24.8276-8288.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Resistance to Tumor Necrosis Factor-Induced Cell
Death Mediated by PMCA4 Deficiency

and
*
Corresponding author. Mailing address: Department of
Immunology IMM-32, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037. Phone: (858) 784-8704. Fax: (858) 784-8665. E-mail: jhan{at}scripps.edu.
This is publication no. 14231-IMM from the Department of
Immunology, The Scripps Research Institute, La Jolla, Calif.
Present address: Avigen, Inc., Alameda, CA 94502.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»